Pederiva C.; Gazzotti M.; Arca M.; Averna M.; Banderali G.; Biasucci G.; Brambilla M.; Buonuomo P.S.; Calabro P.; Cipollone F.; Citroni N.; D'Addato S.; Del Ben M.; Genovesi S.; Guardamagna O.; Iannuzzo G.; Iughetti L.; Mandraffino G.; Maroni L.; Mombelli G.; Muntoni S.; Nascimbeni F.; Passaro A.; Pellegatta F.; Pirro M.; Pisciotta L.; Pujia R.; Sarzani R.; Scicali R.; Suppressa P.; Zambon S.; Zenti M.G.; Calandra S.; Catapano A.L.; Tarugi P.; Galimberti F.; Casula M.; Capra M.E., Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group, «NUTRIENTS», 2023, 15, Article number: 3468 , pp. 1 - 10 [Scientific article]
Baracchi A, Piani F, Degli Esposti D, Agnoletti D, Borghi C, D'Addato S; Bologna HDP Study Group., Correction to: When pregnancy-associated hypertriglyceridemia goes above and beyond the risk of pancreatitis, «INTERNAL AND EMERGENCY MEDICINE», 2023, 18, pp. 1877 - 1877 [Scientific article]
Bilato C.; Zambon A.; Pisciotta L.; Citroni N.; Carrubbi F.; Zambon S.; Zenti M.G.; Vinci P.; Biolo G.; Bonomo K.; Egalini F.; Passaro A.; Nascimbeni F.; Negri E.; D'Addato S.; Averna M.; Arca M.; Oliva F.; Colivicchi F.; Catapano A., Identifying possible homozygous familial hypercholesterolemia patients: An Italian experts' opinion, «GIORNALE ITALIANO DI CARDIOLOGIA», 2023, 24, pp. 5 - 10 [Scientific article]
Larrey D.; D'Erasmo L.; O'Brien S.; Arca M.; Cefalù A.B.; Di Costanzo A.; Bini S.; Giammanco A.; Averna M.; Iannuzzo G.; Fortunato G.; Gentile M.; Di Taranto M.D.; Pujia A.; Montalcini T.; Pavanello C.; Calabresi L.; Vigna G.B.; Bucci M.; Bonomo K.; Sampietro T.; Sbrana F.; Suppressa P.; Sabbà C.; Fimiani F.; Cesaro A.; Calabrò P.; Ventura F.; D’Addato S.; Pisciotta L.; Bertolini S., Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia, «LIVER INTERNATIONAL», 2023, 43, pp. 413 - 423 [Scientific article]Open Access
Fogacci F, Giovannini M, Imbalzano E, Grandi E, Rizzoli E, D'Addato S, Cicero AFG, Metabolic and vascular effect of a new standardized bergamot phytocomplex: a three-arm, placebocontrolled, double-blind clinical trial, «ARCHIVES OF MEDICAL SCIENCE», 2023, 19, pp. 1228 - 1235 [Scientific article]Open Access
D'Addato S.; Borghi C., Regression of atherosclerosis and platelet stabilization: Therapeutic objectives to confront, «GIORNALE ITALIANO DI CARDIOLOGIA», 2023, 10, pp. 13s - 17s [Scientific article]
Cicero AFG, Fogacci F, D'Addato S, Grandi E, Rizzoli E, Borghi C, On Behalf Of The Brisighella Heart Study., Self-Reported Coffee Consumption and Central and Peripheral Blood Pressure in the Cohort of the Brisighella Heart Study., «NUTRIENTS», 2023, 15, Article number: 312 , pp. 1 - 10 [Scientific article]Open Access
Cicero AFG, Fogacci F, Giovannini M, Rizzoli E, Grandi E, D'Addato S, Borghi C., The Effect of Dietary Supplementation with Plant Sterols on Total and LDL-Cholesterol in Plasma Is Affected by Adherence to Mediterranean Diet: Insights from the DESCO Randomized Clinical Study, «NUTRIENTS», 2023, 15, pp. 1 - 13 [Scientific article]
Cicero AFG, Fogacci F, Tocci G, D'Addato S, Grandi E, Banach M, Borghi C., Three arms, double-blind, non-inferiority, randomized clinical study testing the lipid-lowering effect of a novel dietary supplement containing red yeast rice and artichoke extracts compared to Armolipid Plus® and placebo, «ARCHIVES OF MEDICAL SCIENCE», 2023, 19, pp. 1169 - 1179 [Scientific article]Open Access
Baracchi, Alessandro; Piani, Federica; Degli Esposti, Daniela; Agnoletti, Davide; Borghi, Claudio; D'Addato, Sergio, When pregnancy-associated hypertriglyceridemia goes above and beyond the risk of pancreatitis, «INTERNAL AND EMERGENCY MEDICINE», 2023, 2023 Jul 19, pp. 1 - 5 [Scientific article]
Cicero AFG, Fogacci F, Rizzoli E, D'Addato S, Borghi C; Brisighella Heart Study Group, Correction: Cicero et al. Long-Term Impact of Different Triple Combination Antihypertensive Medications on Blood Pressure Control, Metabolic Pattern and Incident Events: Data from the Brisighella Heart Study. J. Clin. Med. 2021, 10, 5921., «JOURNAL OF CLINICAL MEDICINE», 2022, 11, pp. 7109 - 7109 [Comment or similar]
Morieri M.L.; Lamacchia O.; Manzato E.; Giaccari A.; Avogaro A.; Amoresano L.; Angotti S.; Bartone L.; Caraffa F.; Carboni A.; Carro S.; Cervone S.; Clerico A.; Console I.; Conti D.M.; D'Addato S.; de Bellis A.; de Meo F.; di Carlo A.; di Cianni G.; di Giovanni G.; di Lembo S.; Diacono F.; Dolcino M.; Elia G.; Elli P.; Fatone C.; Galli A.; Galluzzo G.; Garzaniti A.; Ghelardi R.; Giacchini A.; Giunta L.; Golia F.; Gregorio F.; Ierna D.; Lampitella A.; Luciano A.; Maffettone A.; Mancini R.; Mangone I.; Mantovani L.E.; Marangoni A.; Marelli G.; Marin N.; Marino G.; Mastromatteo E.; Mazziotti G.; Me E.; Memoli G.; Menicatti L.S.M.; Moffa S.; Moise' M.; Monaco F.; Morgante S.N.; Pellicano F.; Petraroli E.; Piersanti D.; Pipitone A.; Puglisi S.; Rinaldi M.; Rizzo M.; Rosco M.; Scollo G.; Simioni N.; Squadrone M.; Sturniolo G.; Tedeschi A.; Tizio B.; Ugolotti D.; Valente L.; Vinci C.; Zenoni L.; Zenti M.G., Correction to: Physicians’ misperceived cardiovascular risk and therapeutic inertia as determinants of low LDL-cholesterol targets achievement in diabetes (Cardiovascular Diabetology, (2022), 21, 1, (57), 10.1186/s12933-022-01495-8), «CARDIOVASCULAR DIABETOLOGY», 2022, 21, Article number: 73 , pp. 73 - 84 [Scientific article]
Fogacci F, Rizzoli E, Giovannini M, Bove M, D'Addato S, Borghi C, Cicero AFG, Effect of Dietary Supplementation with Eufortyn® Colesterolo Plus on Serum Lipids, Endothelial Reactivity, Indexes of Non-Alcoholic Fatty Liver Disease and Systemic Inflammation in Healthy Subjects with Polygenic Hypercholesterolemia: The ANEMONE Study. Nutrients. 2022 May 18;14(10):209, «NUTRIENTS», 2022, 14, Article number: 2099 , pp. 1 - 11 [Scientific article]Open Access
Cicero A.F.G.; Fogacci F.; Rizzoli E.; Giovannini M.; D'Addato S.; Borghi C.; Grandi E.; Ventura F.; Coppola P.; Ianniello E.; Soldati M.; Piani F.; Iamino I.R.; Palmisano S.; Landolfo M.; Bacchelli S., Impact of simultaneous management of hypertension and hypercholesterolemia with ACE inhibitors and statins on cardiovascular outcomes in the Brisighella Heart Study: A 8-year follow-up, «NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES», 2022, 32, pp. 2246 - 2254 [Scientific article]
Cicero AFG, Fogacci F, Derosa G, D'Angelo A, Ventura F, Rizzoli E, D'Addato S, Borghi C, On Behalf Of The Brisighella Heart Study Group, Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study, «BIOMEDICINES», 2022, 10, Article number: 656 , pp. 1 - 11 [Scientific article]Open Access
